Cipla Limited has announced the opening of a special window for the lodgement of transfer and dematerialisation of physical shares, following a directive from the Securities and Exchange Board of India (SEBI). This initiative provides eligible shareholders with an opportunity to convert their physical share certificates to electronic form and complete pending transfer processes.

SEBI Directive and Timeline

The pharmaceutical company issued the notice pursuant to SEBI Circular No. HO/3R/11/2026-MIRSD-PODI/37/50/2026 dated January 30, 2026. The special window will remain operational until February 4, 2027, giving shareholders nearly a year to complete their transfer and dematerialisation requirements.

Eligibility Criteria

Cipla has provided a detailed matrix outlining the eligibility conditions for shareholders to utilise this special window:

Exclusions and Restrictions

The company has specified that certain cases will not be considered under this special window:

• Cases involving disputes between transferor and transferee
• Shares which have been transferred to Investor Education and Protection Fund (IEPF)

Lock-in Period and Conditions

Shares lodged for transfer pursuant to this circular will be issued exclusively in dematerialised form and will be subject to a lock-in period of one year from the date of registration of transfer. During this lock-in period, such shares cannot be transferred or pledged.

Process and Contact Information

Eligible shareholders wishing to avail this opportunity must submit requisite documents to KFIN Technologies Limited, the company's Registrar and Share Transfer Agent. The documents should be sent to their Hyderabad office located at Selenium Tower B, Plot No. 31 & 32, Gachibowli, Nanakramguda, Serilingampally, Hyderabad, Telangana - 500 032.

For queries, shareholders can raise service requests at sivward@cskinfotech.com or cossecretary@cipla.com . The company has encouraged shareholders to take advantage of this special window introduced in their interest.

Cipla Limited has successfully concluded its postal ballot process, with shareholders approving all four proposed resolutions with strong majorities. The pharmaceutical company announced the results on 26th March, 2026, following the completion of the e-voting process that concluded on 25th March, 2026.

Leadership Appointments Approved

Shareholders demonstrated strong support for the company's leadership changes, approving the appointment of Mr Achin Gupta (DIN: 09491674) in multiple capacities. The voting results showed overwhelming approval across all shareholder categories.

Voting Participation and Process

The postal ballot process witnessed significant shareholder participation, with 650905507 votes cast representing 80.58% of the total outstanding shares of 807780677. The e-voting facility was provided by National Securities Depository Limited (NSDL), ensuring a transparent and efficient voting process.

Shareholder Category Participation

Scrutinizer's Oversight

The voting process was overseen by Mr Avinash Bagul, Partner at M/s BNP & Associates, who was appointed as scrutinizer through a Board Resolution dated 23rd January, 2026. The scrutinizer confirmed that all resolutions were passed with requisite majorities and that the e-voting process was conducted in a fair and transparent manner.

The postal ballot notice was sent to 574481 members whose email addresses were registered with the company, out of a total of 591086 members as on the record date of 20th February, 2026. The e-voting period commenced on 24th February, 2026 at 9.00 a.m. and concluded on 25th March, 2026 at 5.00 p.m.

Regulatory Compliance

The postal ballot process was conducted in compliance with Section 108 and Section 110 of the Companies Act, 2013, along with relevant rules and SEBI Listing Regulations. The company published advertisements in "Business Standard" English newspaper and "Sakal" Marathi newspaper on 24th February, 2026, providing requisite information to shareholders.

The voting results and scrutinizer's report have been uploaded on the company's website at www.cipla.com and on NSDL's e-voting platform at www.evoting.nsdl.com , ensuring transparency and accessibility for all stakeholders.